EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Potential for anti‑angiogenic therapy targeting the receptor for advanced glycation end products/VEGF axis in ulcerative colitis (Review)

Chen Xu, Yuting Li, Yahua Hong, Dayong Zhou, Kun He, Lianghui Wang, Feng Hong

Molecular Medicine Reports · 09.04.2026 · 33 (6) · 1-14

DOI: 10.3892/mmr.2026.13876 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Medicine Reports, online erschienen am 09.04.2026. Verfasst von Chen Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Medicine, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui 230031, P.R. China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Receptor for Advanced Glycation End Products, Vascular Endothelial Growth Factor A, Angiogenesis Inhibitors. Die Arbeit nennt 260 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeReceptor for Advanced Glycation End ProductsVascular Endothelial Growth Factor AAngiogenesis InhibitorsNeovascularization, PathologicHumansSignal TransductionAnimalsMolecular Targeted TherapyGlycation End Products, Advanced

Stichwörter der Autor:innen

angiogenesisreceptor for advanced glycation end productstargeted therapiesulcerative colitisvascular endothelial growth factor

Substanzen

Receptor for Advanced Glycation End ProductsVascular Endothelial Growth Factor AAngiogenesis InhibitorsGlycation End Products, Advanced

Autor:innen und Institutionen

  • Department of Intensive Care Medicine, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui 230031, P.R. China.
  • Hospital Infection Management Department, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui 230031, P.R. China.

Zitieren

APA

Xu, C., Li, Y., Hong, Y., Zhou, D., He, K., Wang, L., & Hong, F. (2026). Potential for anti‑angiogenic therapy targeting the receptor for advanced glycation end products/VEGF axis in ulcerative colitis (Review). Molecular Medicine Reports, 33(6), 1-14. https://doi.org/10.3892/mmr.2026.13876

Vancouver

Xu C, Li Y, Hong Y, Zhou D, He K, Wang L, et al. Potential for anti‑angiogenic therapy targeting the receptor for advanced glycation end products/VEGF axis in ulcerative colitis (Review). Molecular Medicine Reports. 2026;33(6):1-14. doi:10.3892/mmr.2026.13876

BibTeX
@article{Xu2026,
  author = {Xu, Chen and Li, Yuting and Hong, Yahua and Zhou, Dayong and He, Kun and Wang, Lianghui and Hong, Feng},
  title = {Potential for anti‑angiogenic therapy targeting the receptor for advanced glycation end products/VEGF axis in ulcerative colitis (Review)},
  journal = {Molecular Medicine Reports},
  year = {2026},
  volume = {33},
  number = {6},
  pages = {1--14},
  doi = {10.3892/mmr.2026.13876}
}
Kostenlos starten →